𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antisense strategies for the treatment of hematological malignancies and solid tumors

✍ Scribed by R. Kronenwett; R. Haas


Publisher
Springer
Year
1998
Tongue
English
Weight
698 KB
Volume
77
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


11. Antisense oligonucleotides in the tr
✍ A. Chybicka; R. Chaber; J. Toporski; M. Ussowicz πŸ“‚ Article πŸ“… 2001 πŸ› Wielkopolskie Centrum Onkologii 🌐 Polish βš– 98 KB

sister (20 x 10 6 CD34 cells/kg). As acute graft versus host disease prophylaxis she received cyclosporin A (1,5 mg/kg from day -1). From day +16 we observed aGVHD ,,0 in the skin and gastrointestinal tract. Administration of metylprednisolon in max. dose of 1,5 mg/kg proved effecttive. No toxicity

Erythropoietin for the treatment of anem
✍ T. J. Littlewood πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 152 KB

## Abstract Anemia is common in patients with hematological malignancy. Most patients will have their anemia attributed to the anemia of chronic disease. The anemia of chronic disease is caused by cytokine mediated suppression of erythropoiesis and low serum erythropoietin levels are found in the m

Clinical implications of tumor-associate
✍ James M. Pluda; David R. Parkinson πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 855 KB

There is now a substantial body of evidence that tumor growth is angiogenesisdependent, and that neovascularization is also necessary for tumor invasion and metastasis. In addition, the assessment of microvessel count or density in a primary tumor may ultimately prove to be a significant and indepen